257 related articles for article (PubMed ID: 17848677)
1. Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death.
Jiang H; Gomez-Manzano C; Aoki H; Alonso MM; Kondo S; McCormick F; Xu J; Kondo Y; Bekele BN; Colman H; Lang FF; Fueyo J
J Natl Cancer Inst; 2007 Sep; 99(18):1410-4. PubMed ID: 17848677
[TBL] [Abstract][Full Text] [Related]
2. The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells.
Berghauser Pont LM; Kleijn A; Kloezeman JJ; van den Bossche W; Kaufmann JK; de Vrij J; Leenstra S; Dirven CM; Lamfers ML
PLoS One; 2015; 10(5):e0127058. PubMed ID: 25993039
[TBL] [Abstract][Full Text] [Related]
3. Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death.
Alonso MM; Jiang H; Yokoyama T; Xu J; Bekele NB; Lang FF; Kondo S; Gomez-Manzano C; Fueyo J
Mol Ther; 2008 Mar; 16(3):487-93. PubMed ID: 18253154
[TBL] [Abstract][Full Text] [Related]
4. Targeting brain tumor stem cells with oncolytic adenoviruses.
Alonso MM; Jiang H; Gomez-Manzano C; Fueyo J
Methods Mol Biol; 2012; 797():111-25. PubMed ID: 21948473
[TBL] [Abstract][Full Text] [Related]
5. Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway.
Fueyo J; Alemany R; Gomez-Manzano C; Fuller GN; Khan A; Conrad CA; Liu TJ; Jiang H; Lemoine MG; Suzuki K; Sawaya R; Curiel DT; Yung WK; Lang FF
J Natl Cancer Inst; 2003 May; 95(9):652-60. PubMed ID: 12734316
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagy.
Ulasov IV; Shah N; Kaverina NV; Lee H; Lin B; Lieber A; Kadagidze ZG; Yoon JG; Schroeder B; Hothi P; Ghosh D; Baryshnikov AY; Cobbs CS
Oncotarget; 2015 Feb; 6(6):3977-87. PubMed ID: 25738357
[TBL] [Abstract][Full Text] [Related]
7. Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells.
Yokoyama T; Iwado E; Kondo Y; Aoki H; Hayashi Y; Georgescu MM; Sawaya R; Hess KR; Mills GB; Kawamura H; Hashimoto Y; Urata Y; Fujiwara T; Kondo S
Gene Ther; 2008 Sep; 15(17):1233-9. PubMed ID: 18580968
[TBL] [Abstract][Full Text] [Related]
8. Combination treatment for glioblastoma cells with tumor necrosis factor-related apoptosis-inducing ligand and oncolytic adenovirus delta-24.
Tsamis KI; Alexiou GA; Vartholomatos E; Kyritsis AP
Cancer Invest; 2013 Nov; 31(9):630-8. PubMed ID: 24164301
[TBL] [Abstract][Full Text] [Related]
9. Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma.
Ulasov IV; Zhu ZB; Tyler MA; Han Y; Rivera AA; Khramtsov A; Curiel DT; Lesniak MS
Hum Gene Ther; 2007 Jul; 18(7):589-602. PubMed ID: 17630837
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity.
Piao Y; Jiang H; Alemany R; Krasnykh V; Marini FC; Xu J; Alonso MM; Conrad CA; Aldape KD; Gomez-Manzano C; Fueyo J
Cancer Gene Ther; 2009 Mar; 16(3):256-65. PubMed ID: 18927600
[TBL] [Abstract][Full Text] [Related]
11. Eradication of brain tumor stem cells with an oncolytic adenovirus.
Jiang H; Fueyo J
Discov Med; 2010 Jul; 10(50):24-8. PubMed ID: 20670595
[TBL] [Abstract][Full Text] [Related]
12. Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas.
Yong RL; Shinojima N; Fueyo J; Gumin J; Vecil GG; Marini FC; Bogler O; Andreeff M; Lang FF
Cancer Res; 2009 Dec; 69(23):8932-40. PubMed ID: 19920199
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus expressing dual c-Met-specific shRNA exhibits potent antitumor effect through autophagic cell death accompanied by senescence-like phenotypes in glioblastoma cells.
Lee JS; Oh E; Yoo JY; Choi KS; Yoon MJ; Yun CO
Oncotarget; 2015 Feb; 6(6):4051-65. PubMed ID: 25726528
[TBL] [Abstract][Full Text] [Related]
14. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
[TBL] [Abstract][Full Text] [Related]
15. The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models.
Martínez-Vélez N; Garcia-Moure M; Marigil M; González-Huarriz M; Puigdelloses M; Gallego Pérez-Larraya J; Zalacaín M; Marrodán L; Varela-Guruceaga M; Laspidea V; Aristu JJ; Ramos LI; Tejada-Solís S; Díez-Valle R; Jones C; Mackay A; Martínez-Climent JA; García-Barchino MJ; Raabe E; Monje M; Becher OJ; Junier MP; El-Habr EA; Chneiweiss H; Aldave G; Jiang H; Fueyo J; Patiño-García A; Gomez-Manzano C; Alonso MM
Nat Commun; 2019 May; 10(1):2235. PubMed ID: 31138805
[TBL] [Abstract][Full Text] [Related]
16. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus.
Ito H; Aoki H; Kühnel F; Kondo Y; Kubicka S; Wirth T; Iwado E; Iwamaru A; Fujiwara K; Hess KR; Lang FF; Sawaya R; Kondo S
J Natl Cancer Inst; 2006 May; 98(9):625-36. PubMed ID: 16670388
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic adenoviruses for the treatment of brain tumors.
Gomez-Manzano C; Fueyo J
Curr Opin Mol Ther; 2010 Oct; 12(5):530-7. PubMed ID: 20886384
[TBL] [Abstract][Full Text] [Related]
18. An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus.
Phillips LM; Li S; Gumin J; Daou M; Ledbetter D; Yang J; Singh S; Parker Kerrigan BC; Hossain A; Yuan Y; Gomez-Manzano C; Fueyo J; Lang FF
Neuro Oncol; 2021 Nov; 23(11):1911-1921. PubMed ID: 34059921
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma.
Sonabend AM; Ulasov IV; Tyler MA; Rivera AA; Mathis JM; Lesniak MS
Stem Cells; 2008 Mar; 26(3):831-41. PubMed ID: 18192232
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas.
Jiang H; Gomez-Manzano C; Lang FF; Alemany R; Fueyo J
Curr Gene Ther; 2009 Oct; 9(5):422-7. PubMed ID: 19860656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
